These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

794 related articles for article (PubMed ID: 27099234)

  • 1. BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance.
    Tasdemir N; Banito A; Roe JS; Alonso-Curbelo D; Camiolo M; Tschaharganeh DF; Huang CH; Aksoy O; Bolden JE; Chen CC; Fennell M; Thapar V; Chicas A; Vakoc CR; Lowe SW
    Cancer Discov; 2016 Jun; 6(6):612-29. PubMed ID: 27099234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC4 degradation during senescence unleashes an epigenetic program driven by AP-1/p300 at selected enhancers and super-enhancers.
    Di Giorgio E; Paluvai H; Dalla E; Ranzino L; Renzini A; Moresi V; Minisini M; Picco R; Brancolini C
    Genome Biol; 2021 May; 22(1):129. PubMed ID: 33966634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma.
    Sengupta D; Kannan A; Kern M; Moreno MA; Vural E; Stack B; Suen JY; Tackett AJ; Gao L
    Epigenetics; 2015; 10(6):460-6. PubMed ID: 25941994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype.
    Bossi D; Cicalese A; Dellino GI; Luzi L; Riva L; D'Alesio C; Diaferia GR; Carugo A; Cavallaro E; Piccioni R; Barberis M; Mazzarol G; Testori A; Punzi S; Pallavicini I; Tosti G; Giacó L; Melloni G; Heffernan TP; Natoli G; Draetta GF; Minucci S; Pelicci P; Lanfrancone L
    Cancer Discov; 2016 Jun; 6(6):650-63. PubMed ID: 27179036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation.
    Stratton MS; Bagchi RA; Felisbino MB; Hirsch RA; Smith HE; Riching AS; Enyart BY; Koch KA; Cavasin MA; Alexanian M; Song K; Qi J; Lemieux ME; Srivastava D; Lam MPY; Haldar SM; Lin CY; McKinsey TA
    Circ Res; 2019 Sep; 125(7):662-677. PubMed ID: 31409188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. lncRNA JPX-Enriched Chromatin Microenvironment Mediates Vascular Smooth Muscle Cell Senescence and Promotes Atherosclerosis.
    Gu J; Chen J; Yin Q; Dong M; Zhang Y; Chen M; Chen X; Min J; He X; Tan Y; Zheng L; Jiang H; Wang B; Li X; Chen H
    Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):156-176. PubMed ID: 37942612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senescence Can Be BETter without the SASP?
    Vizioli MG; Adams PD
    Cancer Discov; 2016 Jun; 6(6):576-8. PubMed ID: 27261480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNAs interact with BRD4 to promote enhanced chromatin engagement and transcription activation.
    Rahnamoun H; Lee J; Sun Z; Lu H; Ramsey KM; Komives EA; Lauberth SM
    Nat Struct Mol Biol; 2018 Aug; 25(8):687-697. PubMed ID: 30076409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-766-5p Targets Super-Enhancers by Downregulating CBP and BRD4.
    Gen Y; Muramatsu T; Inoue J; Inazawa J
    Cancer Res; 2021 Oct; 81(20):5190-5201. PubMed ID: 34353856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone H4 acetylation and the epigenetic reader Brd4 are critical regulators of pluripotency in embryonic stem cells.
    Gonzales-Cope M; Sidoli S; Bhanu NV; Won KJ; Garcia BA
    BMC Genomics; 2016 Feb; 17():95. PubMed ID: 26847871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone Acetyltransferase p300 Induces De Novo Super-Enhancers to Drive Cellular Senescence.
    Sen P; Lan Y; Li CY; Sidoli S; Donahue G; Dou Z; Frederick B; Chen Q; Luense LJ; Garcia BA; Dang W; Johnson FB; Adams PD; Schultz DC; Berger SL
    Mol Cell; 2019 Feb; 73(4):684-698.e8. PubMed ID: 30773298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrate metabolism controls the senescent microenvironment via the remodeling of pro-inflammatory enhancers.
    Etoh K; Araki H; Koga T; Hino Y; Kuribayashi K; Hino S; Nakao M
    Cell Rep; 2024 Aug; 43(8):114496. PubMed ID: 39043191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MacroH2A1 and ATM Play Opposing Roles in Paracrine Senescence and the Senescence-Associated Secretory Phenotype.
    Chen H; Ruiz PD; McKimpson WM; Novikov L; Kitsis RN; Gamble MJ
    Mol Cell; 2015 Sep; 59(5):719-31. PubMed ID: 26300260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer.
    Zuber V; Bettella F; Witoelar A; ; ; ; ; Andreassen OA; Mills IG; Urbanucci A
    BMC Genomics; 2017 Mar; 18(1):270. PubMed ID: 28359301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of chromatin and transcriptional co-regulators in mediating p63-genome interactions in keratinocytes.
    Sethi I; Sinha S; Buck MJ
    BMC Genomics; 2014 Nov; 15(1):1042. PubMed ID: 25433490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BET Proteins Are Required for Transcriptional Activation of the Senescent Islet Cell Secretome in Type 1 Diabetes.
    Thompson PJ; Shah A; Apostolopolou H; Bhushan A
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional CRISPR screen identifies AP1-associated enhancer regulating FOXF1 to modulate oncogene-induced senescence.
    Han R; Li L; Ugalde AP; Tal A; Manber Z; Barbera EP; Chiara VD; Elkon R; Agami R
    Genome Biol; 2018 Aug; 19(1):118. PubMed ID: 30119690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA1 mutations attenuate super-enhancer function and chromatin looping in haploinsufficient human breast epithelial cells.
    Zhang X; Wang Y; Chiang HC; Hsieh YP; Lu C; Park BH; Jatoi I; Jin VX; Hu Y; Li R
    Breast Cancer Res; 2019 Apr; 21(1):51. PubMed ID: 30995943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRD4 promotes p63 and GRHL3 expression downstream of FOXO in mammary epithelial cells.
    Nagarajan S; Bedi U; Budida A; Hamdan FH; Mishra VK; Najafova Z; Xie W; Alawi M; Indenbirken D; Knapp S; Chiang CM; Grundhoff A; Kari V; Scheel CH; Wegwitz F; Johnsen SA
    Nucleic Acids Res; 2017 Apr; 45(6):3130-3145. PubMed ID: 27980063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of tumor oncogenes by disruption of super-enhancers.
    Lovén J; Hoke HA; Lin CY; Lau A; Orlando DA; Vakoc CR; Bradner JE; Lee TI; Young RA
    Cell; 2013 Apr; 153(2):320-34. PubMed ID: 23582323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.